Precision Reimbursement for Precision Medicine: Using Real‐World Evidence to Evolve From Trial‐and‐Project to Track‐and‐Pay to Learn‐and‐Predict-Reference-Cited by-同舟云学术

Precision Reimbursement for Precision Medicine: Using Real‐World Evidence to Evolve From Trial‐and‐Project to Track‐and‐Pay to Learn‐and‐Predict

Published:2021-11-17 Issue:1 Volume:111 Page:52-62
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Eichler Hans‐Georg¹^ORCID,Trusheim Mark²^ORCID,Schwarzer‐Daum Brigitte¹,Larholt Kay²,Zeitlinger Markus¹,Brunninger Martin³,Sherman Michael⁴⁵,Strutton David⁶,Hirsch Gigi²^ORCID

Affiliation:

1. Medical University of Vienna Vienna Austria

2. Massachusetts Institute of Technology Center for Biomedical Innovation Cambridge Massachusetts USA

3. Dachverband der Sozialversicherungsträger Vienna Austria

4. Point32Health Wellesley Massachusetts USA

5. Department of Population Medicine Harvard Medical School Boston Massachusetts USA

6. Merck & Co., Inc. Kenilworth New Jersey USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2471

Reference65 articles.

1. Wartman L.&Cavallo J.O.Without genomic sequencing I would not be alive today.The ASCO Post (2018). Accessed August 2021. Story of how Washington University genetics researchers identified the gene mutation driving the ALL (acute lymphoblastic leukemia) of their colleague Dr. Lukas Wartman to repurpose a kidney cancer to put the ALL into remission (wild‐typeFLT3overexpression treated with sunitinib [Sutent]).

2. Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease

3. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead

4. Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth

5. Lautscham G.&Mullner S.Beyond oncology – precision medicine for autoimmune disease. Life science leader (2017). Accessed August 2021.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®);Value in Health;2024-08

2. Personalisierte Medizin in der Onkologie;Die Pathologie;2024-04-03

3. Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach;Journal of Pharmaceutical Policy and Practice;2023-07-05

4. Orphan drugs’ clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement;Frontiers in Pharmacology;2023-01-26

5. Towards Autonomous Healthcare: Integrating Artificial Intelligence (AI) for Personalized Medicine and Disease Prediction;SSRN Electronic Journal;2023